NATHAN MINER: Open Payments
NPI 1932793478 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,647 in 146 payments from 16 companies in 2025. Trend: 2023 $2,226 · 2024 $8,819 · 2025 $6,647
Speaker / faculty: $4,000Food & beverage: $2,552Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $4,669 |
| Lundbeck LLC | 25 | $368 |
| Otsuka America Pharmaceutical, Inc. | 14 | $313 |
| Vanda Pharmaceuticals Inc. | 11 | $245 |
| E.R. Squibb & Sons, L.L.C. | 13 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $210 |
| Alkermes, Inc. | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Indivior Inc. | 4 | $77 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, TRINTELLIX, Auvelity.
Industry payments across IN — which companies pay providers there.
